研究者
J-GLOBAL ID:201801016549468030
更新日: 2025年03月09日 大石 智洋
オオイシ トモヒロ | Tomohiro Oishi
- Oishi T, Yasui Y, Kato A, Ogita S, Eitoku T, Enoki H, Nakano T. Analysis of Cell Immunity for Children Infected with SARS-CoV-2 and Those Vaccinated against SARS-CoV-2 Using T-SPOT®.COVID. Microorganisms. 2024. 12. 5
- Tomohiro Oishi, Satoshi Hasegawa, Tokushi Nakano, Shoji Sudo, Hiroaki Kuwajima, Shuko Tokuriki, Tsutomu Tamura. Changes in vaccine coverage and incidence of acute gastroenteritis and severe rotavirus gastroenteritis in children <5 years in Shibata City, Niigata Prefecture, Japan. Human Vaccines & Immunotherapeutics. 2024. 20. 1
- Tomohiro Oishi, Nemu Hattori, Daisuke Yoshioka. Novel Knowledge of Macrolide Resistance in Mycoplasma pneumoniae by Azithromycin Exposure. Microorganisms2024. 2024. 12巻. 1
- Kenri T, Yamazaki T, Ohya H, Jinnai M, Oda Y, Asai S, Sato R, Ishiguro N, Oishi T, Horino A, et al. Genotyping of Mycoplasma pneumoniae strains isolated in Japan during 2019 and 2020: spread of p1 gene type 2c and 2j variant strains. Antimicrobials, Resistance and Chemotherapy. 2023. 14巻
- Tomohiro Oishi, Daisuke Yoshioka, Takashi Nakano, Kazunobu Ouchi. Recent Trend of Antimicrobial Susceptibility among Mycoplasma pneumoniae Isolated from Japanese Children. Microorganisms. 2022. 10. 12
- 長山 香織, 大石 智洋, 石松 昌己, 藤井 哲英, 萱 智史, 吉岡 大介. Tazobactam/ceftolozaneの多剤耐性グラム陰性桿菌に対する薬剤感受性検査の検討. 日本化学療法学会雑誌. 2022. 70. 5. 402-407
- Tomohiro Oishi, Kazunobu Ouchi. Recent Trends in the Epidemiology, Diagnosis, and Treatment of Macrolide-Resistant Mycoplasma pneumoniae. Journal of Clinical Medicine. 2022. 11. 7. 1782-1782
- Tanaka Y, Miyata I, Nakamura Y, Kondo E, Gotoh K, Oishi T, Nakano T, Ouchi K. Characteristics and etiology of infection in febrile infants aged ≤90 days. Pediatrics International. 2022. 64. 1. e15040
- 坂田瑶子, 大石智洋, 宮田一平, 北野太一, 光井康次郎, 井上智貴, 髙橋研斗, 若林尚子, 河野美奈, 加藤敦, et al. ESBL産生菌の増加を想定した小児上部尿路感染症における治療方針の検討. 小児感染免疫. 2021. 33. 4. 333-342
- Tanaka Y, Oishi T, Ono S, Kono M, Kato A, Miyata I, Ohno N, Ouchi K. Epidemiology of urinary tract infections in children: Causative bacteria and antimicrobial therapy. Pediatrics International. 2021. 63. 10. 1198-1204
- 大石智洋, 田中知暁, 野村信彦. 小児におけるキノロン系抗菌薬トスフロキサシンの有効性に関するPK/PD解析に基づいた牛乳併用の影響に関する検討. 診療と新薬. 2021. 58. 9. 694-697
- Oishi T, Muratani T, Tanaka T, Sato M, Urara K, Ouchi K, Iwata S, Matsumoto T, Nakahama C. Study of Normal Flora in the Pharynx of Healthy Children. Japanese Journal of Infectious Diseases. 2021. 74. 5. 450-457
- Yoshitaka Nakamura, Tomohiro Oishi, Kazunari Kaneko, Tsuyoshi Kenri, Takaaki Tanaka, Shoko Wakabayashi, Mina Kono, Sahoko Ono, Atsushi Kato, Eisuke Kondo, et al. Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children. Journal of Infection and Chemotherapy. 2021. 27. 2. 271-276
- Tomohiro Oishi, Aki Saito, Yoko Fukuda, Atsushi Kato, Eisuke Kondo, Hideto Teranishi, Hiroto Akaike, Ippei Miyata, Naoki Ohno, Kazunobu Ouchi. Analysis of risk factors for multidrug-resistant pathogens and appropriate treatment indications for pneumonia in children with neurologic impairment. Journal of Infection and Chemotherapy. 2021. 27. 2. 342-347
- 髙橋研斗, 大石智洋, 井上智貴, 若林尚子, 河野美奈, 加藤敦, 寺西英人, 赤池洋人, 田中孝明, 宮田一平, et al. ガイドラインに基づいた小児の市中肺炎に対する注射抗菌薬アンピシリンによる初期治療の検証. 小児感染免疫. 2020. 32. 4. 324-332
- 井上智貴, 大石智洋, 髙橋研斗, 若林尚子, 河野美奈, 加藤敦, 赤池洋人, 田中孝明, 宮田一平, 大野直幹, et al. 川崎医科大学小児科における最近10年間のマイコプラズマ入院例についての検討. 小児感染免疫. 2020. 32. 4. 345-351
- Tomohiro Oishi, Yoko Fukuda, Shoko Wakabayashi, Mina Kono, Sahoko Ono, Atsushi Kato, Eisuke Kondo, Yoshitaka Nakamura, Yuhei Tanaka, Hideto Teranishi, et al. Low prevalence of Chlamydia pneumoniae infections during the Mycoplasma pneumoniae epidemic season: Results of nationwide surveillance in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2020. 26. 11. 1116-1121
- 大石智洋. 【抗菌薬の「なぜ?」に答える】肺炎マイコプラズマのマクロライド耐性率はなぜ変化(増減)したのか?. 小児内科. 2020. 52. 10. 1519-1522
- Tomohiro Oishi, Masamichi Matsunaga, Tokushi Nakano, Shoji Sudo, Hiroaki Kuwajima, Shuko Tokuriki, Shibata RVGE Study. Occurrence of severe rotavirus gastroenteritis in children younger than three years of age before and after the introduction of rotavirus vaccine: a prospective observational study in four pediatric clinics in Shibata City, Niigata Prefecture, Japan. Human Vaccines & Immunotherapeutics. 2020. 1-7
- 大石智洋. 耐性菌全国調査、新規遺伝子迅速診断からみた小児での治療法の変化. 日本マイコプラズマ学会雑誌. 2020. 46. 86-88
前のページに戻る